Koninklijke Philips Nv
$40.13B- Market cap
- $24.94B
- Debt
- +$15.86B
- Cash
- −$2.79B
Capital structure 61% equity / 39% debt · EV / Revenue 1.94x · EV / EBITDA 29.14x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: PHG stock price vs VALE: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VALE's multiple
Needs VALE P/E.
Implied fair value · at PHG's multiple
Needs EPS (TTM).
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PHG FY 2025 (ended Dec 31, 2025) · VALE FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 61% equity / 39% debt · EV / Revenue 1.94x · EV / EBITDA 29.14x
Capital structure 56% equity / 44% debt · EV / Revenue 2.87x
VALE carries the larger enterprise value at $110.03B against $40.13B; PHG trades on the lower EV / Revenue multiple (1.94x vs 2.87x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
KONINKLIJKE PHILIPS NV · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
VALE S.A. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Net debt / EBITDA
Leverage against operating earnings
11.03x
—
Cash and equivalents
Liquid reserves on the balance sheet
$2.79B
$7.37B
Total debt
Interest-bearing obligations outstanding
$15.86B
$52.18B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
GE HealthCare Technologies Inc.
PHG vs GEHC
HOLOGIC INC
PHG vs HOLX
BOSTON SCIENTIFIC CORP
PHG vs BSX
INTUITIVE SURGICAL INC
PHG vs ISRG
ZIMMER BIOMET HOLDINGS, INC.
PHG vs ZBH
BHP Group Ltd
PHG vs BHP
FREEPORT-MCMORAN INC
PHG vs FCX
SOUTHERN COPPER CORP/
PHG vs SCCO
NEWMONT Corp /DE/
PHG vs NEM
TECK RESOURCES LTD
PHG vs TECK
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.